Comparison of the EORTC QLQ‐BM22 and the BOMET‐QOL quality of life questionnaires in patients with bone metastases
暂无分享,去创建一个
[1] Liying Zhang,et al. International field testing of the reliability and validity of the EORTC QLQ‐BM22 module to assess health‐related quality of life in patients with bone metastases , 2012, Cancer.
[2] A. Bottomley,et al. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases , 2009, Expert review of pharmacoeconomics & outcomes research.
[3] Liying Zhang,et al. Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases. , 2009, European journal of cancer.
[4] A. Bezjak,et al. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. , 2009, European journal of cancer.
[5] X. Badia,et al. Impact of skeletal complications on patients’ quality of life, mobility, and functional independence , 2008, Supportive Care in Cancer.
[6] X. Badia,et al. Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia , 2007 .
[7] A. Bottomley,et al. Quality of life and symptom end points in palliative bone metastases trials. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).